319 related articles for article (PubMed ID: 31707804)
1. Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.
Natsuaki M; Morimoto T; Shiomi H; Yamaji K; Watanabe H; Shizuta S; Kato T; Ando K; Nakagawa Y; Furukawa Y; Tada T; Nagao K; Kadota K; Toyofuku M; Kimura T
Circ Cardiovasc Interv; 2019 Nov; 12(11):e008307. PubMed ID: 31707804
[TBL] [Abstract][Full Text] [Related]
2. Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Intervention - From the CREDO-Kyoto Registry Cohort-3.
Natsuaki M; Morimoto T; Shiomi H; Ehara N; Taniguchi R; Tamura T; Tada T; Suwa S; Kaneda K; Watanabe H; Tazaki J; Watanabe S; Yamamoto E; Saito N; Fuki M; Takeda T; Eizawa H; Shinoda E; Mabuchi H; Shirotani M; Uegaito T; Matsuda M; Takahashi M; Inoko M; Tamura T; Ishii K; Onodera T; Sakamoto H; Aoyama T; Sato Y; Ando K; Furukawa Y; Nakagawa Y; Kadota K; Kimura T;
Circ J; 2021 May; 85(6):769-781. PubMed ID: 33298644
[TBL] [Abstract][Full Text] [Related]
3. Validation of the academic research consortium high bleeding risk definition in Thai PCI registry.
Roongsangmanoon W; Wongsoasup A; Chichareon P; Suwannasom P; Chandavimol M; Limpijankit T; Srimahachota S; Hutayanon P; Kiatchoosakun S; Siriwiwattnakul N; Promlikitchai P; Siriyotha S; Thakkinstian A; Sansanayudh N
Int J Cardiol; 2023 Oct; 388():131167. PubMed ID: 37429447
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
Sorrentino S; Claessen BE; Chandiramani R; Guedeney P; Vogel B; Baber U; Rau V; Wang J; Krucoff M; Kozuma K; Ge J; Seth A; Makkar R; Liu Y; Bangalore S; Bhatt DL; Angiolillo DJ; Saito S; Neumann FJ; Hermiller J; Valgimigli M; Mehran R
Circulation; 2020 Mar; 141(11):891-901. PubMed ID: 31992063
[TBL] [Abstract][Full Text] [Related]
5. Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry.
Sorrentino S; Sartori S; Baber U; Claessen BE; Giustino G; Chandrasekhar J; Chandiramani R; Cohen DJ; Henry TD; Guedeney P; Ariti C; Dangas G; Gibson CM; Krucoff MW; Moliterno DJ; Colombo A; Vogel B; Chieffo A; Kini AS; Witzenbichler B; Weisz G; Steg PG; Pocock S; Urban P; Mehran R
Circ Cardiovasc Interv; 2020 Apr; 13(4):e008226. PubMed ID: 32216472
[TBL] [Abstract][Full Text] [Related]
6. Sex-Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient-Level Pooled Analysis From 4 Postapproval Studies.
Chandiramani R; Cao D; Claessen BE; Sorrentino S; Guedeney P; Blum M; Goel R; Roumeliotis A; Krucoff M; Kozuma K; Ge J; Seth A; Makkar R; Bangalore S; Bhatt DL; Angiolillo DJ; Ruster K; Wang J; Saito S; Neumann FJ; Hermiller J; Valgimigli M; Mehran R
J Am Heart Assoc; 2020 Apr; 9(7):e014611. PubMed ID: 32223396
[TBL] [Abstract][Full Text] [Related]
7. Transradial vs. Transfemoral Percutaneous Coronary Intervention in Patients With or Without High Bleeding Risk Criteria.
Yamamoto K; Natsuaki M; Morimoto T; Shiomi H; Watanabe H; Yamaji K; Watanabe H; Kato T; Saito N; Ando K; Kadota K; Furukawa Y; Kimura T;
Circ J; 2020 Apr; 84(5):723-732. PubMed ID: 32188831
[TBL] [Abstract][Full Text] [Related]
8. Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome.
Shimono H; Tokushige A; Kanda D; Ohno A; Hayashi M; Fukuyado M; Akao M; Kawasoe M; Arikawa R; Otsuji H; Chaen H; Okui H; Oketani N; Ohishi M
J Cardiol; 2023 Jun; 81(6):553-563. PubMed ID: 36682715
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of the Academic Research Consortium for High Bleeding Risk Criteria and Prognostic Value of a Simplified Definition.
Miura K; Shimada T; Ohya M; Murai R; Amano H; Kubo S; Tada T; Tanaka H; Fuku Y; Goto T; Kadota K
Circ J; 2020 Aug; 84(9):1560-1567. PubMed ID: 32669530
[TBL] [Abstract][Full Text] [Related]
10. Comparison and Validation of Long-Term Bleeding Events for Academic Bleeding Risk (ARC-HBR) Criteria and Contemporary Risk Scores for Percutaneous Coronary Intervention With a Second-Generation Drug Eluting Stent.
Okabe K; Miura K; Shima Y; Ikuta A; Taguchi Y; Takahashi K; Osakada K; Ohya M; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
Circ J; 2022 Aug; 86(9):1379-1387. PubMed ID: 35400715
[TBL] [Abstract][Full Text] [Related]
11. Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCI.
Wang HY; Dou KF; Yin D; Zhang D; Gao RL; Yang YJ
BMC Cardiovasc Disord; 2020 Jul; 20(1):313. PubMed ID: 32611318
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients.
Cao D; Mehran R; Dangas G; Baber U; Sartori S; Chandiramani R; Stefanini GG; Angiolillo DJ; Capodanno D; Urban P; Morice MC; Krucoff M; Goel R; Roumeliotis A; Sweeny J; Sharma SK; Kini A
J Am Coll Cardiol; 2020 Jun; 75(21):2711-2722. PubMed ID: 32466887
[TBL] [Abstract][Full Text] [Related]
13. Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies.
Yoshikawa Y; Shiomi H; Watanabe H; Natsuaki M; Kondo H; Tamura T; Nakagawa Y; Morimoto T; Kimura T
Circulation; 2018 Feb; 137(6):551-562. PubMed ID: 28982692
[TBL] [Abstract][Full Text] [Related]
14. Applicability of the Academic Research Consortium for High Bleeding Risk in acute coronary syndrome undergoing percutaneous coronary intervention.
Abu-Assi E; Raposeiras-Roubín S; Cespón Fernández M; Caneiro Queija B; Melendo Viu M; Íñiguez Romo A
Rev Esp Cardiol (Engl Ed); 2022 May; 75(5):375-383. PubMed ID: 33865751
[TBL] [Abstract][Full Text] [Related]
15. Validation of the academic research consortium high bleeding risk criteria in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of 10 studies and 67,862 patients.
Silverio A; Di Maio M; Buccheri S; De Luca G; Esposito L; Sarno G; Vecchione C; Galasso G
Int J Cardiol; 2022 Jan; 347():8-15. PubMed ID: 34774882
[TBL] [Abstract][Full Text] [Related]
16. Incidence and outcomes of high bleeding risk patients with type 1 and type 2 myocardial infarction in a community-based cohort: Application of the Academic Research Consortium High Bleeding Risk Criteria.
Breen TJ; Raphael CE; Ingraham B; Lane C; Huxley S; Roger VL; Jaffe A; Lewis B; Sandoval YB; Prasad A; Rihal CS; Gulati R; Singh M
Int J Cardiol; 2024 Feb; 396():131565. PubMed ID: 37913957
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of the Japanese high bleeding risk criteria and its prognostic significance for fatal bleeding in patients with acute myocardial infarction.
Sotomi Y; Hikoso S; Nakatani D; Suna S; Dohi T; Mizuno H; Okada K; Kida H; Oeun B; Sunaga A; Sato T; Kitamura T; Sakata Y; Sato H; Hori M; Komuro I; Sakata Y;
Heart Vessels; 2021 Oct; 36(10):1484-1495. PubMed ID: 33743047
[TBL] [Abstract][Full Text] [Related]
18. Sex-Based Differences in Bleeding Risk After Percutaneous Coronary Intervention and Implications for the Academic Research Consortium High Bleeding Risk Criteria.
Spirito A; Gragnano F; Corpataux N; Vaisnora L; Galea R; Svab S; Gargiulo G; Siontis GCM; Praz F; Lanz J; Billinger M; Hunziker L; Stortecky S; Pilgrim T; Capodanno D; Urban P; Pocock S; Mehran R; Heg D; Windecker S; Räber L; Valgimigli M
J Am Heart Assoc; 2021 Jun; 10(12):e021965. PubMed ID: 34098740
[TBL] [Abstract][Full Text] [Related]
19. High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry.
Nakamura M; Kadota K; Nakao K; Nakagawa Y; Shite J; Yokoi H; Kozuma K; Tanabe K; Iijima R; Harada A; Kuroda T; Murakami Y
EuroIntervention; 2021 Feb; 16(14):1154-1162. PubMed ID: 32624464
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Domestic High Bleeding Risk Criteria for Japanese Patients with Acute Myocardial Infarction.
Matsumoto T; Saito Y; Sato T; Yamashita D; Suzuki S; Saito K; Wakabayashi S; Kitahara H; Sano K; Kobayashi Y
J Atheroscler Thromb; 2023 Mar; 30(3):299-309. PubMed ID: 35613875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
